Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Generate Biomedicines, Inc.
GENB
Net margin
Net margin at other companies
Repligen
RGEN
17.1%
-3.7pp
Piper Sandler
PIPR
14%
+0.8pp
MYR Group
MYRG
3.7%
+2.7pp
NNN REIT
NNN
41.4%
-3.7pp
CHE
Chemed
CHE
10.2%
-2.2pp
AppFolio
APPF
15.3%
-8.6pp
Other financials
Income statement
See full
Revenue
$7.2M
-18.1%
Operating income
-$64.1M
-33.1%
Net income
-$61.4M
-47.4%
EPS (diluted)
-$1.07
+34.0%
Balance sheet
See full
Cash & equivalents
$160.6M
-27.2%
Total debt
$65.6M
—
Total equity
$514.8M
+209%
Total assets
$625.7M
—
Cash flow
See full
Operating cash flow
-$80.4M
-51.2%
CapEx
$3.8M
+403%
Free cash flow
-$84.2M
-56.1%
Valuation
See full
Market cap
$1.86B
—
Enterprise value
$1.76B
—
Returns & leverage
See full
Debt / equity
0.1×
—
Current ratio
9.2×
—